Back

Indexes of anticoagulation control and major adverse outcomes in patients with atrial fibrillation: an analysis from the AFFIRM Trial

19 March 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 3 - Atrial Fibrillation - Stroke Prevention Oral Anticoagulation EHRA Premium Access EHRA 2019

About the speaker

Photo
Associate Professor Marco Proietti

University of Milan, Milan (Italy)

8 More presentations in this session

Presentation thumbnail
Associate Professor M. Proietti (Milan, IT)
Abstract Slides
Presentation thumbnail
Doctor B. Slavchev (Sofia, BG)
Abstract Slides
Presentation thumbnail
Doctor A. Bodin (Chambray Les Tours, FR)
Abstract
Presentation thumbnail
Doctor C. Tomasi (Ravenna, IT)
Abstract
Presentation thumbnail
Professor J. Camm (London, GB)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Atrial Fibrillation - Stroke Prevention

The Event

Event poster

EHRA 2019

19 March 2019 08:30 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Presentation
State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources